🇺🇸 FDA
Patent

US 10899829

Emapii neutralizing antibody limits influenza A virus (IAV)-induced lung injury

granted A61KA61K2039/505A61K39/3955

Quick answer

US patent 10899829 (Emapii neutralizing antibody limits influenza A virus (IAV)-induced lung injury) held by United States Government as represented by the Department of Veterans Affairs expires Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States Government as represented by the Department of Veterans Affairs
Grant date
Tue Jan 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K2039/505, A61K39/3955, A61K45/06, A61P